Merck Manual

Please confirm that you are a health care professional

honeypot link



Brian J. Werth

, PharmD, University of Washington School of Pharmacy

Last review/revision May 2022 | Modified Sep 2022
View Patient Education

Aztreonam is currently the only available monobactam. Aztreonam has activity similar to that of ceftazidime against

Aztreonam shares structural similarities with few other beta-lactams, making cross-hypersensitivity unlikely, except with ceftazidime and cefiderocol, which have similar R1 side chains. Thus, aztreonam is used mainly for severe aerobic gram-negative bacillary infections (including meningitis Acute Bacterial Meningitis Acute bacterial meningitis is rapidly progressive bacterial infection of the meninges and subarachnoid space. Findings typically include headache, fever, and nuchal rigidity. Diagnosis is by... read more ) in patients who have a serious beta-lactam allergy but who nevertheless require beta-lactam therapy. Aztreonam is also not labile to metallo-beta-lactamases and can therefore be useful for some infections in which resistance to other beta-lactam antibiotics is mediated by that enzyme.

Other antibiotics are added to cover any suspected gram-positive species or anaerobes.

The dose of aztreonam is reduced in renal failure.

Drugs Mentioned In This Article

Drug Name Select Trade
Azactam, Cayston
Ceptaz, Fortaz, Tazicef, Tazidime
View Patient Education
NOTE: This is the Professional Version. CONSUMERS: View Consumer Version
quiz link

Test your knowledge

Take a Quiz!